{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:18:04Z","timestamp":1780100284875,"version":"3.54.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-025-04728-0","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:00:57Z","timestamp":1767477657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of mercaptopurine schedule on hypoglycemia in leukemic children: randomized trial and risk factor analysis"],"prefix":"10.1038","author":[{"given":"Zhi-Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Ru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu\u2011Hua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Fang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan\u2011Lai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"4728_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1116864","volume":"14","author":"C Worth","year":"2023","unstructured":"Worth, C. et al. Continuous glucose monitoring for children with hypoglycaemia: evidence in 2023. Front. Endocrinol. 14, 1116864 (2023).","journal-title":"Front. Endocrinol."},{"key":"4728_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fendo.2013.00060","volume":"4","author":"HB Avatapalle","year":"2013","unstructured":"Avatapalle, H. B. et al. Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism. Front. Endocrinol. 4, 60 (2013).","journal-title":"Front. Endocrinol."},{"key":"4728_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/MPH.0000000000002609","volume":"45","author":"K Albiroty","year":"2023","unstructured":"Albiroty, K. & Sabahi, A. A. Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in 2 children with acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 45, 162\u2013163 (2023).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4728_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.6065\/apem.2018.23.4.226","volume":"23","author":"EM Cho","year":"2018","unstructured":"Cho, E. M., Moon, J. E., Lee, S. J. & Ko, C. W. Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in a child with acute lymphoblastic leukemia. Ann. Pediatr. Endocrinol. Metab. 23, 226\u2013228 (2018).","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"4728_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/pbc.24928","volume":"61","author":"S Melachuri","year":"2014","unstructured":"Melachuri, S., Gandrud, L. & Bostrom, B. The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia. Pediatr. Blood Cancer. 61, 1003\u20131006 (2014).","journal-title":"Pediatr. Blood Cancer."},{"key":"4728_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27577","volume":"66","author":"MB Miller","year":"2019","unstructured":"Miller, M. B., Brackett, J., Schafer, E. S. & Rau, R. E. Prevention of mercaptopurine induced hypoglycemia using allopurinol to reduce methylated thiopurine metabolites. Pediatr. Blood Cancer 66, e27577 (2019).","journal-title":"Pediatr. Blood Cancer"},{"key":"4728_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/pbc.20582","volume":"47","author":"A Bay","year":"2006","unstructured":"Bay, A. et al. Symptomatic hypoglycemia: an unusual side effect of oral purine analogues for treatment of ALL. Pediatr. Blood Cancer. 47, 330\u2013331 (2006).","journal-title":"Pediatr. Blood Cancer."},{"key":"4728_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/pch\/pxad019","volume":"28","author":"M Jiang","year":"2023","unstructured":"Jiang, M. & Ahmet, A. Hypoglycemia during treatment of acute lymphoblastic leukemia. Paediatr. Child Health. 28, 305\u2013306 (2023).","journal-title":"Paediatr. Child Health."},{"key":"4728_CR9","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1097\/MPH.0b013e3182025507","volume":"33","author":"MK El-Bitar","year":"2011","unstructured":"El-Bitar, M. K., Muwakkit, S. A. & Dabbagh, O. Severe hypoglycemic seizures in a child receiving 6-mercaptopurine. J. Pediatr. Hematol. Oncol. 33, e75\u2013e76 (2011).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4728_CR10","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3109\/10428194.2011.580024","volume":"52","author":"J Trelinska","year":"2011","unstructured":"Trelinska, J. et al. Hypoglycemia and glycemic variability among children with acute lymphoblastic leukemia during maintenance therapy. Leuk. Lymphoma 52, 1704\u20131710 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"4728_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1067\/mpd.2001.111273","volume":"138","author":"P Halonen","year":"2001","unstructured":"Halonen, P., Salo, M. K. & M\u00e4kipernaa, A. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia. J. Pediatr. 138, 428\u2013431 (2001).","journal-title":"J. Pediatr."},{"key":"4728_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/mpo.10097","volume":"39","author":"O Ziino","year":"2002","unstructured":"Ziino, O. et al. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood Acute lymphoblastic leukemia. Med. Pediatr. Oncol. 39, 32\u201334 (2002).","journal-title":"Med. Pediatr. Oncol."},{"key":"4728_CR13","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/sj.leu.2403783","volume":"19","author":"M Aric\u00f3","year":"2005","unstructured":"Aric\u00f3, M. et al. The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29-30, 2005. Leukemia 19, 1145\u20131152 (2005).","journal-title":"Leukemia"},{"key":"4728_CR14","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1200\/JCO.2016.71.7579","volume":"35","author":"W Landier","year":"2017","unstructured":"Landier, W. et al. Mercaptopurine ingestion habits, red cell thioguanine nucleotide levels, and relapse risk in children with acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group Study AALL03N1. J. Clin. Oncol. 35, 1730\u20131736 (2017).","journal-title":"J. Clin. Oncol."},{"key":"4728_CR15","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/pbc.26028","volume":"63","author":"J Samis","year":"2016","unstructured":"Samis, J. et al. Recognizing endocrinopathies associated with tyrosine kinase inhibitor therapy in children with chronic myelogenous leukemia. Pediatr. Blood Cancer 63, 1332\u20131338 (2016).","journal-title":"Pediatr. Blood Cancer"},{"key":"4728_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/193229681200600107","volume":"6","author":"EV Faustino","year":"2012","unstructured":"Faustino, E. V., Hirshberg, E. L. & Bogue, C. W. Hypoglycemia in critically ill children. J. Diabetes Sci. Technol. 6, 48\u201357 (2012).","journal-title":"J. Diabetes Sci. Technol."},{"key":"4728_CR17","first-page":"493","volume":"47","author":"H Li","year":"2009","unstructured":"Li, H., Ji, C. Y., Zong, X. N. & Zhang, Y. Q. Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years. Chin J. Pediatr. 47, 493\u2013498 (2009).","journal-title":"Chin J. Pediatr."},{"key":"4728_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29467","volume":"69","author":"E Rosenfeld","year":"2022","unstructured":"Rosenfeld, E. et al. Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemia. Pediatr. Blood Cancer 69, e29467 (2022).","journal-title":"Pediatr. Blood Cancer"},{"key":"4728_CR19","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1097\/MPH.0000000000002818","volume":"46","author":"RJ Mary","year":"2024","unstructured":"Mary, R. J. et al. Hypoglycemia Associated With PEG-asparaginase and 6-MP Therapy During Treatment of Acute Lymphoblastic Leukemia in Pediatric Patients: A Case Series. J. Pediatr. Hematol. Oncol. 46, e121\u2013e126 (2024).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4728_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/scipharm86020018","volume":"86","author":"S Supandi","year":"2018","unstructured":"Supandi, S., Harahap, Y., Harmita, H. & Andalusia, R. Quantification of 6-Mercaptopurine and its metabolites in patients with acute lymphoblastic leukemia using dried blood spots and UPLC-MS\/MS. Sci. Pharm. 86, 18 (2018).","journal-title":"Sci. Pharm."},{"key":"4728_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/00498254.2019.1688424","volume":"50","author":"AM Marinaki","year":"2020","unstructured":"Marinaki, A. M. & Arenas-Hernandez, M. Reducing risk in thiopurine therapy. Xenobiotica. 50, 101\u2013109 (2020).","journal-title":"Xenobiotica."},{"key":"4728_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MPH.0000000000000499","volume":"38","author":"NM Giamanco","year":"2016","unstructured":"Giamanco, N. M. et al. Allopurinol use during maintenance therapy for acute lymphoblastic leukemia avoids mercaptopurine-related hepatotoxicity. J. Pediatr. Hematol. Oncol. 38, 147\u2013151 (2016).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4728_CR23","volume":"7","author":"T Barone","year":"2024","unstructured":"Barone, T., Dandekar, S., McKeone, D. & Mulieri, K. Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy. Cancer Rep. 7, e1987 (2024).","journal-title":"Cancer Rep."},{"key":"4728_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.12688\/f1000research.17760.2","volume":"8","author":"M Zhang","year":"2019","unstructured":"Zhang, M. & Bostrom, B. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia. F1000Res. 8, 176 (2019).","journal-title":"F1000Res."},{"key":"4728_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.yapd.2008.07.008","volume":"55","author":"FM Hoe","year":"2008","unstructured":"Hoe, F. M. Hypoglycemia in infants and children. Adv. Pediatr. 55, 367\u2013384 (2008).","journal-title":"Adv. Pediatr."},{"key":"4728_CR26","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1200\/OP.20.00652","volume":"17","author":"A Mohamed","year":"2021","unstructured":"Mohamed, A. et al. Reducing morning hypoglycemia among children undergoing treatment for acute lymphoblastic leukemia. JCO Oncol. Pract. 17, e901\u2013e907 (2021).","journal-title":"JCO Oncol. Pract."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04728-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04728-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04728-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T23:02:11Z","timestamp":1767481331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04728-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":26,"alternative-id":["4728"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04728-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from the parents of the study participants before enrollment in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}